Since TNF is also an essential mediator in several forms of acute hepatitis (Hasselblatt et al, 2007), we evaluated the therapeutic potential of miR-511 in the concanavalin (ConA) model of acute, TNF-mediated hepatitis (Hasselblatt et al, 2007). This evidence concerns the gene TNF and hepatitis A virus infection.